UNC Metastatic Cancer Radiation Therapy Registry
UNC Lineberger Comprehensive Cancer Center
2,000 participants
Apr 21, 2024
OBSERVATIONAL
Conditions
Summary
The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.
Eligibility
Inclusion Criteria5
- Written informed consent was obtained to participate in the study and HIPAA
- Authorization for release of personal health information. Ability to understand and willingness to sign informed consent
- Diagnosed with or is suspected to have metastatic cancer.
- Age ≥ 18 years at the time of consent.
- Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.
Exclusion Criteria1
- Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects with metastatic cancer receive radiation therapy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06306924